How Immunotherapy Is Rewriting the Rules of Liver Cancer Treatment
A sweeping review details how immune checkpoint inhibitors, combination regimens, CAR-T cells, vaccines, and oncolytic viruses are transforming treatment of ...
A sweeping review details how immune checkpoint inhibitors, combination regimens, CAR-T cells, vaccines, and oncolytic viruses are transforming treatment of ...
A new first-person perspective in Advances in Therapy follows a music professor through repeated myeloma relapses to talquetamab therapy, revealing ...
A German analysis of insurance billing and nationwide hospital data finds that CAR-T therapy for diffuse large B-cell lymphoma carries ...
A large single-center study found that nearly 58 percent of patients undergoing hematopoietic cell transplantation or CAR-T therapy develop orthostatic ...
A new review in Holistic Integrative Oncology details how mesenchymal stem cells, renal progenitor cells, and exosomes could protect cancer ...
A new review in Molecular Cancer details how loss of the immune synapse molecule CD58 drives tumor immune evasion and ...
New research shows that the BTK inhibitor ibrutinib activates the protease matriptase in malignant B cells, preserving surface CD19 and ...
A systematic review and meta-analysis of 70 clinical studies finds that newer BTK inhibitors acalabrutinib and zanubrutinib outperform ibrutinib as ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine